Chigene
Latest round
- Series B
Last raised
- Oct 2021
Total raised
- $45M
Investors
- 8
About Chigene
Based in Beijing, China and established in 2012, Chigene is precision medicine company that provides gene and life omics big data precision medicine, tumor precision targeting and neoantigen immunization diagnosis and treatment. The company has built the world's largest database of genotype-phenotype associated genetic diseases for the Chinese population, and developed the world’s first genetic diagnostic platform based on the big data analysis of human genome. It has developed a full spectrum of next generation sequencing (NGS) based sequencing products for tumor therapeutics. Along with the sister company Chineo, perfected the neoantigen technology, it offers personalized immuno-therapies for cancer treatment. Up to 2021, it has been collaborating with more than 100 hospitals national wide, and working along with them towards the goal of building big data based medical diagnostic platform. It also has been collaborating with national medical associations, and the goal of building the genetic diagnostic platform based on the Chinese population. The company has a complete product line to provide an one-stop solution for precision medicine, covering highly integrated sequencing solution for diagnosis, prevention, and management of Mendelian inheritance disease, birth-defects, tumors, chronic diseases, pharmacogenomics, and other health care practices.
Who invested in Chigene
8 investors across 3 rounds
See all investors in Chigene
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Chigene
Who invested in Chigene?
Chigene has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Chigene raised?
Chigene has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Chigene last raise money?
Chigene's most recent round on record is a Series B, in Oct 2021.
What does Chigene do?
Based in Beijing, China and established in 2012, Chigene is precision medicine company that provides gene and life omics big data precision medicine, tumor precision targeting and neoantigen immunization diagnosis and treatment.
Where is Chigene headquartered?
Chigene is headquartered in Beijing, China.
Which VCs invest in companies like Chigene?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Hengxu Capital and Riverhead Capital back healthcare companies at Chigene's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like Chigene? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.